Skip to main content

Table 9 Single factor analysis of death in the three groups

From: Comparison of the clinical and prognosis risk factors between endoscopic resection and radical gastrectomy for early-stage gastric cancer

Characteristic

ESD (n = 139)

P

LARG (n = 108)

P

ORG (n = 170)

P

 

Survival

(n = 131)

Death

(n = 8)

Survival

(n = 101)

Death

(n = 7)

 

Survival

(n = 161)

Death

(n = 9)

 

Sex (%)

  

0.99*

  

0.02*

  

0.99*

 Male

106 (80.9)

7 (87.5)

 

74 (73.3)

2 (28.6)

 

114 (70.8)

7 (77.8)

 

 Female

25 (19.1)

1 (12.5)

 

27 (26.7)

5 (71.4)

 

47 (29.2)

2 (22.2)

 

Year (%)

  

0.99*

  

0.45*

  

0.74*

  ≥ 60

86 (65.6)

3 (37.5)

 

54 (71.4)

5 (71.4)

 

95 (59)

6 (66.7)

 

  < 60

45 (34.4)

5 (62.5)

 

47 (46.5)

2 (28.6)

 

66 (41)

3 (33.3)

 

Location (%)

  

0.12*

  

0.29*

  

0.05*

 Upper

74 (56.5)

3 (37.5)

 

22 (21.8)

2 (28.6)

 

48 (29.8)

0 (0)

 

 Middle

8 (6.1)

2 (25)

 

22 (21.8)

3 (42.9)

 

25 (15.5)

3 (33.3)

 

 Lower

49 (37.4)

3 (37.5)

 

57 (56.4)

2 (28.6)

 

88 (54.7)

6 (66.7)

 

Tumor size (%)

  

 < 0.01*

  

0.41*

  

0.27*

  ≥ 2 cm

34 (26)

7 (87.5)

 

65 (64.4)

6 (85.7)

 

109 (67.7)

8 (88.9)

 

  < 2 cm

97 (74)

1 (12.5)

 

36 (35.6)

1 (14.3)

 

52 (32.3)

1 (11.1)

 

Infiltration depth (%)

  

 < 0.01*

  

0.01*

  

0.03*

 Mucous

107 (81.7)

2 (25)

 

65 (64.4)

0 (0)

 

82 (50.9)

1 (11.1)

 

 Submucous

24 (18.3)

6 (75)

 

36 (35.6)

7 (100)

 

79 (49.1)

8 (88.9)

 

Differentiated degree (%)

  

0.04*

  

0.29*

  

0.03*

 High

80 (61.1)

3 (37.5)

 

15 (14.9)

0 (0)

 

33 (20.5)

0 (0)

 

 Middle

41 (31.3)

2 (25)

 

46 (45.5)

2 (28.6)

 

58 (36.0)

1 (11.1)

 

 Lower

109 (7.6)

3 (37.5)

 

40 (39.6)

5 (71.4)

 

70 (43.5)

8 (88.9)

 

Vascular invasion (%)

  

0.05*

  

0.03*

  

0.03*

 Yes

0 (0)

1 (12.5)

 

3 (3.0)

2 (28.6)

 

4 (2.5)

2 (22.2)

 

 No

131 (100)

7 (87.5)

 

98 (97.0)

5 (71.4)

 

157 (97.5)

7 (77.8)

 

Smoking (%)

  

0.62*

  

0.99*

  

0.67*

 Yes

22 (16.8)

2 (25)

 

21 (20.8)

1 (14.3)

 

29 (18)

2 (22.2)

 

 No

109 (83.2)

6 (75)

 

80 (79.2)

6 (85.1)

 

132 (82)

7 (77.8)

 

Drink (%)

  

0.99*

  

0.99*

  

0.24*

 Yes

14 (10.7)

0 (0)

 

12 (11.9)

1 (14.3)

 

16 (9.9)

2 (22.2)

 

 No

117 (89.3)

8 (100)

 

89 (88.1)

6 (85.7)

 

145 (90.1)

7 (77.8)

 

Diabetes (%)

  

0.99*

  

0.18*

  

0.99*

 Yes

5 (3.8)

0 (0)

 

2 (2.0)

1 (14.3)

 

7 (4.3)

0 (0)

 

 No

126 (96.2)

8 (100)

 

99 (98.0)

6 (85.7)

 

154 (95.7)

9 (100)

 

Atherosis (%)

  

0.35*

  

0.99*

  

0.99*

 Yes

26 (19.8)

0 (0)

 

18 (17.8)

1 (14.3)

 

30 (18.6)

1 (11.1)

 

 No

105 (80.2)

100 (100)

 

83 (82.2)

6 (85.7)

 

131 (81.4)

8 (88.9)

 

Family history (%)

  

0.21*

  

0.99*

  

0.99*

 Yes

3 (2.3)

1 (12.5)

 

3 (3.0)

0 (0)

 

5 (3.1)

0 (0)

 

 No

105 (80.2)

7 (87.5)

 

98 (97.0)

100 (100)

 

155 (98.9)

9 (100)

 

Lymph metastasis (%)

        

0.35*

 Yes

0

0

 

8 (7.9)

1 (14.3)

0.46*

21 (13.0)

2 (22.2)

 

 No

131

8

 

93 (92.1)

6 (83.7)

 

140 (87.0)

7 (77.8)

 
  1. Data are expressed as number (%). ESD: endoscopic submucosal dissection
  2. EMR Endoscopic mucosal resection, LARG Laparoscopic assisted radical gastrectomy, ORG Open radical gastrectomy
  3. *Fisher’s exact test was used
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us